ZyVersa Therapeutics Q1 EPS $(0.22) Up From $(0.73) YoY

Benzinga Newsdesk www.benzinga.com Positive 55.0%

Neg 0% Neu 0% Pos 55%

ZyVersa Therapeutics (OTC:ZVSA) reported quarterly losses of $(0.22) per share. This is a 69.86 percent increase over losses of $(0.73) per share from the same period last year.